Cargando…

Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice

PURPOSE: To study the effect of oxidation on the structure of recombinant human interferon beta-1a (rhIFNβ-1a) and its immunogenicity in wild-type and immune-tolerant transgenic mice. METHODS: Untreated rhIFNβ-1a was degraded by metal-catalyzed oxidation, H(2)O(2)-mediated oxidation, and guanidine-m...

Descripción completa

Detalles Bibliográficos
Autores principales: van Beers, Miranda M. C., Sauerborn, Melody, Gilli, Francesca, Brinks, Vera, Schellekens, Huub, Jiskoot, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170469/
https://www.ncbi.nlm.nih.gov/pubmed/21544687
http://dx.doi.org/10.1007/s11095-011-0451-4
_version_ 1782211629930250240
author van Beers, Miranda M. C.
Sauerborn, Melody
Gilli, Francesca
Brinks, Vera
Schellekens, Huub
Jiskoot, Wim
author_facet van Beers, Miranda M. C.
Sauerborn, Melody
Gilli, Francesca
Brinks, Vera
Schellekens, Huub
Jiskoot, Wim
author_sort van Beers, Miranda M. C.
collection PubMed
description PURPOSE: To study the effect of oxidation on the structure of recombinant human interferon beta-1a (rhIFNβ-1a) and its immunogenicity in wild-type and immune-tolerant transgenic mice. METHODS: Untreated rhIFNβ-1a was degraded by metal-catalyzed oxidation, H(2)O(2)-mediated oxidation, and guanidine-mediated unfolding/refolding. Four rhIFNβ-1a preparations with different levels of oxidation and aggregation were injected intraperitoneally in mice 15× during 3 weeks. Both binding and neutralizing antibodies were measured. RESULTS: All rhIFNβ-1a preparations contained substantial amounts of aggregates. Metal-catalyzed oxidized rhIFNβ-1a contained high levels of covalent aggregates as compared with untreated rhIFNβ-1a. H(2)O(2)-treated rhIFNβ-1a showed an increase in oligomer and unrecovered protein content by HP-SEC; RP-HPLC revealed protein oxidation. Guanidine-treated rhIFNβ-1a mostly consisted of dimers and oligomers and some non-covalent aggregates smaller in size than those in untreated rhIFNβ-1a. All degraded samples showed alterations in tertiary protein structure. Wild-type mice showed equally high antibody responses against all preparations. Transgenic mice were discriminative, showing elevated antibody responses against both metal-catalyzed oxidized and H(2)O(2)-treated rhIFNβ-1a as compared to untreated and guanidine-treated rhIFNβ-1a. CONCLUSIONS: Oxidation-mediated aggregation increased the immunogenicity of rhIFNβ-1a in transgenic mice, whereas aggregated preparations devoid of measurable oxidation levels were hardly immunogenic.
format Online
Article
Text
id pubmed-3170469
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-31704692011-09-26 Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice van Beers, Miranda M. C. Sauerborn, Melody Gilli, Francesca Brinks, Vera Schellekens, Huub Jiskoot, Wim Pharm Res Article PURPOSE: To study the effect of oxidation on the structure of recombinant human interferon beta-1a (rhIFNβ-1a) and its immunogenicity in wild-type and immune-tolerant transgenic mice. METHODS: Untreated rhIFNβ-1a was degraded by metal-catalyzed oxidation, H(2)O(2)-mediated oxidation, and guanidine-mediated unfolding/refolding. Four rhIFNβ-1a preparations with different levels of oxidation and aggregation were injected intraperitoneally in mice 15× during 3 weeks. Both binding and neutralizing antibodies were measured. RESULTS: All rhIFNβ-1a preparations contained substantial amounts of aggregates. Metal-catalyzed oxidized rhIFNβ-1a contained high levels of covalent aggregates as compared with untreated rhIFNβ-1a. H(2)O(2)-treated rhIFNβ-1a showed an increase in oligomer and unrecovered protein content by HP-SEC; RP-HPLC revealed protein oxidation. Guanidine-treated rhIFNβ-1a mostly consisted of dimers and oligomers and some non-covalent aggregates smaller in size than those in untreated rhIFNβ-1a. All degraded samples showed alterations in tertiary protein structure. Wild-type mice showed equally high antibody responses against all preparations. Transgenic mice were discriminative, showing elevated antibody responses against both metal-catalyzed oxidized and H(2)O(2)-treated rhIFNβ-1a as compared to untreated and guanidine-treated rhIFNβ-1a. CONCLUSIONS: Oxidation-mediated aggregation increased the immunogenicity of rhIFNβ-1a in transgenic mice, whereas aggregated preparations devoid of measurable oxidation levels were hardly immunogenic. Springer US 2011-05-05 2011 /pmc/articles/PMC3170469/ /pubmed/21544687 http://dx.doi.org/10.1007/s11095-011-0451-4 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
van Beers, Miranda M. C.
Sauerborn, Melody
Gilli, Francesca
Brinks, Vera
Schellekens, Huub
Jiskoot, Wim
Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
title Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
title_full Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
title_fullStr Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
title_full_unstemmed Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
title_short Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
title_sort oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170469/
https://www.ncbi.nlm.nih.gov/pubmed/21544687
http://dx.doi.org/10.1007/s11095-011-0451-4
work_keys_str_mv AT vanbeersmirandamc oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice
AT sauerbornmelody oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice
AT gillifrancesca oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice
AT brinksvera oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice
AT schellekenshuub oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice
AT jiskootwim oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice